Tes Pharma Srl
PrivateLast Round
Series A
Dec 19, 2024
Total Funding Raised
$15.59M
Company Overview
Tes Pharma Srl is a biotechnology company that develops first-in-class drug candidates for the treatment of oncology, metabolic, and renal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tes Pharma Srl Comparables
Compare Tes Pharma Srl with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sibylla Biotech | 76% | |
| Alfasigma | 72% | |
| OrsoBio | 71% | |
Tes Pharma Srl Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 19, 2024 |
Key People
Founding team and executive leadership
Tes Pharma Srl Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XGEN Venture | Series A |
| Indaco Venture Partners SGR | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2026
Grew 30% QoQ, from 20 to 26 employees.
- Oct 28, 2024
Monthly visitors increased 49% MoM.
Tes Pharma Srl Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tes Pharma Srl's valuation, stock price, and market status.